Diligence memo · auto-generated · as of July 3, 2026
Gemini Bioproducts Holding, Inc.
Gemini Bioproducts Holding, Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Gemini Bioproducts Holding, Inc. operates in Manufacturing, based in WEST SACRAMENTO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Gemini Bioproducts Holding, Inc. has raised $26M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $15M on 2022-05-12.
Most recent recorded round closed around 2024-05-10.
Valuation (modeled)modeled
Provath models Gemini Bioproducts Holding, Inc. at approximately $24M (range $7.9M–$53M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.81× the median modeled value of Series A Manufacturing companies in 2022–2024 (114 peers) — value vs value, same stage and era. Within the normal band (81% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 6 months.
Last raise 2.1 yr ago; this sector typically re-raises about every 12 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
The last round stepped up 2.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 89% of Manufacturing peers (3257 compared).
Modeled value ranks above 67% of those peers.
Closest niche peers: Whitehorse Timber Ventures SPC, Camden Timbers Holdings, LLC, RST Brands, LLC, Plantd, Inc., Sanford Aluminum Group, LLC.
Peoplefiled
17 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.